INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹221 Cr | ₹221 Cr | ₹371 Cr | ₹334 Cr | ₹315 Cr |
What is the latest Total Current Liabilities ratio of INDSWIFT LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹221 Cr |
| Mar2024 | ₹221 Cr |
| Mar2023 | ₹371 Cr |
| Mar2022 | ₹334 Cr |
| Mar2021 | ₹315 Cr |
How is Total Current Liabilities of INDSWIFT LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹221 Cr | -0.31 | |
| Mar2024 | ₹221 Cr | -40.37 | |
| Mar2023 | ₹371 Cr | 10.95 | |
| Mar2022 | ₹334 Cr | 6.34 | |
| Mar2021 | ₹315 Cr | - | |
Compare Total Current Liabilities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹2,725.7 Cr | 10.1% | 35.4% | 204.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,675.0 Cr | -3% | -2.6% | 21.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,516.0 Cr | -0.5% | 17% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,190.0 Cr | 0.6% | 2.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,523.0 Cr | -2.2% | 0.8% | -2.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,493.4 Cr | -1.1% | -1.6% | -0.8% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 10.1% |
35.4% |
204.8% |
| SENSEX | -1% |
0.7% |
-3.6% |
You may also like the below Video Courses